Effect of acute anti-amyloid monoclonal antibody ponezumab (PF-04360365) dosing on Aβ fractional clearance rate in subjects with mild Alzheimer's disease and in healthy volunteers

David Raunig, Aaron Burstein, Carol Cronenberger, Niels Andreasen, Rene Lopez, James Kupiec, Martin Bednar
  • Alzheimer s & Dementia, July 2012, Elsevier
  • DOI: 10.1016/j.jalz.2012.05.1215
The author haven't finished explaining this publicationThe author haven't finished explaining this publication
The following have contributed to this page: Dr Martin M Bednar